Medscape2h
Seasonal Flu Shot: First Defense Against an Eventful Avian Influenza Pandemic
Seasonal influenza vaccines triggered protective immune responses against the H5N1 avian influenza virus primarily in younger ...
Too Old to Operate1d
Neuraminidase in Influenza Vaccines and Expert Consensus on Benefits
The following is a summary of “Expert consensus on the benefits of neuraminidase in conventional influenza vaccines: a Delphi study,” published in the January 2025 issue of Infectious Disease by ...
No, we're not 'one mutation away' from an H5N1 bird flu pandemic. Here are the facts
In early December 2024, a group of researchers published an article in the journal Science, entitled "A single mutation in ...
LTS Wins Funding From BARDA's Patch Forward Prize Competition For Two Partnerships
January 2025 – LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading Pharmaceutical technology company, is proud to announces ...
Stanford’s Vaccine Breakthrough Boosts Flu Protection Like Never Before
Stanford Medicine researchers have developed a new method for influenza vaccination that encourages a robust immune response ...
Small antibody offers broad protection against influenza
Researchers at the University of Gothenburg, Sweden, in collaboration with colleagues in China, have discovered an ...
LTS Wins Funding From BARDA's Patch Forward Prize Competition For Two Partnerships Media Outreach Newswire APAC
ANDERNACH, GERMANY - Newsaktuell - 14 January 2025 - LTS LOHMANN Therapie-Systeme AG (LTS), a leading <a target=_blank href= ...
Forbes21d
Influenza Viruses: What’s In A Name?
The term “hemagglutinin” derives from two parts ... shift are why public health authorities recommend getting an influenza vaccine each year. Every year, leveraging a global system of viral ...
GEN27d
Flu Vaccine Response Boosted by Coupling Antigens from Multiple Subtypes
Hemagglutinin is the principal antigen in the influenza vaccine. The standard flu vaccine contains a mix of four versions of hemagglutinin—one for each of four commonly circulating influenza ...
Pharmaceutical Technology9d
Coronavirus Disease 2019 (COVID-19) + influenza vaccine by Pfizer for Unspecified Influenza Virus Infections: Likelihood of Approval
Coronavirus Disease 2019 (COVID-19) + influenza vaccine is under clinical development by Pfizer and currently in Phase III for Unspecified Influenza Virus Infections.